GSK
GSK Plc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
GlaxoSmithKline PLC (GSK) is a leading global biopharmaceutical company based in Brentford, UK, committed to improving health outcomes through its innovative portfolio which includes pharmaceuticals, vaccines, and consumer healthcare products. With a strong emphasis on research and development, GSK ...
$58.29
-1.42% ($0.84)
Volume
3.17M
52W High
$61.70
52W Low
$32.38
Market Cap
$72.79B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.20
Whisper EPS
$1.30
8.4% above consensus
Last Quarter
$0.70
Current Streak
8 Beats
Avg Surprise (4Q)
+15.21%
Next Earnings Report
Reports in 55 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 4, 2026
1-Day:
+3.39%
5-Day:
+3.11%
Q3 2025
Oct 29, 2025
1-Day:
+2.20%
5-Day:
+0.91%
Q2 2025
Jul 30, 2025
1-Day:
-4.67%
5-Day:
-3.31%
Q1 2025
Apr 30, 2025
1-Day:
-2.76%
5-Day:
-2.51%
Revenue & Financial Performance
Revenue Whisper
$8.25B
TWN Proprietary Estimate
Last Quarter Revenue
$8.51B
+4.8% YoY
Gross Margin
69.4%
Net Margin: 7.4%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $8.51B | +4.8% | 69.4% | 11.2% | $627.7M |
| Q3'25 | $8.55B | +6.7% | 73.6% | 30.3% | $2.01B |
| Q2'25 | $7.99B | +1.3% | 72.9% | 25.3% | $1.44B |
| Q1'25 | $7.52B | +2.1% | 74.2% | 29.5% | $1.62B |
| Q4'24 | $8.12B | +0.8% | 68.5% | 8.6% | $414.0M |
| Q3'24 | $8.01B | -1.7% | 70.1% | 2.4% | -$58.0M |
| Q2'24 | $7.88B | +9.8% | 73.1% | 20.9% | $1.17B |
| Q1'24 | $7.36B | +5.9% | 73.2% | 20.2% | $1.05B |
Company Information
Symbol
GSK
Company
GSK Plc
Market Cap
$72.79B
Sector
HEALTHCARE
Next Earnings
Apr 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as GSK
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare GSK with competitors
Side-by-side earnings comparison